InvestorsHub Logo
Followers 14
Posts 853
Boards Moderated 0
Alias Born 07/18/2014

Re: Joe89 post# 194

Thursday, 04/07/2016 3:41:52 PM

Thursday, April 07, 2016 3:41:52 PM

Post# of 372
RLYP has a 6 month head start on the only other hyperkalemia drug on the horizon. It's superior to that drug, and that other drug sold for $2Billion.

The premium for RLYP is much higher than $24.